DE3006216C2 - Monacolin K, Verfahren zu dessen Herstellung und diese Verbindung enthaltende Arzneimittel - Google Patents
Monacolin K, Verfahren zu dessen Herstellung und diese Verbindung enthaltende ArzneimittelInfo
- Publication number
- DE3006216C2 DE3006216C2 DE3006216A DE3006216A DE3006216C2 DE 3006216 C2 DE3006216 C2 DE 3006216C2 DE 3006216 A DE3006216 A DE 3006216A DE 3006216 A DE3006216 A DE 3006216A DE 3006216 C2 DE3006216 C2 DE 3006216C2
- Authority
- DE
- Germany
- Prior art keywords
- monacolin
- compound
- ferm
- culture medium
- monascus ruber
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/30—Oxygen atoms, e.g. delta-lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
- C12N1/145—Fungal isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/02—Oxygen as only ring hetero atoms
- C12P17/06—Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/645—Fungi ; Processes using fungi
Description
Farblose Kristalle.
C 7ί,56% Η 8,85%
C24H36O5.
Unlöslich in Peiroläther und Hexan.
bei Ratten
bei Kaninchen
Claims (3)
- Patentansprüche:
1. Monacolin K der Formel IHOund durch Behandlung der Verbindung (I) mit Alkalien und Ansäuern erhältliche Säure. - 2. Verfahren zur Herstellung der Verbindung nach Anspruch I1 dadurch gekennzeichnet, daß man jeweils in an sich bekannter Weise Monascus ruber Stamm 1005 (FERM 4822) in einem geeigneten Kulturmedium bei 7 bis 400C aerob züchtet und die Verbindung gemäß Anspruch 1 aus dem Kulturmedium gewinnt
- 3. Arzneimittel mit antihypercholesterämischer und antihyperlipämischer Wirkung, enthaltend die Verbindung nach Anspruch 1 und einen pharmazeutisch geeigneten Träger bzw. ein pharmazeutisch geeignetes Verdünnungsmittel und gegebenenfalls übliche Zusätze.und die durch Behandlung der Verbindung (I) mit Alkalien und Ansäuern erhältliche Säure.Die Erfindung betrifft außerdem ein Verfahren zur Herstellung von Monacolin K. das darin besteht, daß man jeweils in an sich bekannter Weise Monascus ruber Stamm 1005 (FERM 4822) in einem geeigneten Kulturmedium bei 7 bis 400C aerob züchtet und die Verbindung (I) aus dem Kulturmedium gewinnt Gegenstand der Erfindung ist außerdem ein Arzneimittel mit antihypercholesterämischer und antihyperlipämischer Wirkung, welches die Verbindung (I) oder die angegebene Säure und einen pharmazeutisch geeigneten Träger bzw. ein pharmazeutisch geeignetes Verdünnungsmittel und gegebenenfalls übliche Zusätze, enthältMonascus ruber Stamm 1005 (FERM 4822) ist ein neu isolierter Mikroorganismus, der die nachstehend angegebenen mikrobiologischen Eigenschaften besitzt Er wurde aus in Thailand hergestellten Nahrungsmittelnisoliert und am 16. Februar 1979 unter der Hinterlcgungs· Nf. FERm 4822 beim Fermentation Research institute, Agency of Industrial Science and Technology, Ministry of International Trade and Industry, Japan, hinterlegt und unter der Hinterlegungsnummer FERM BP-682 in die internationale Hinterlegungsstelle überführt Unter der Hinterlegungsnummer NRRL 12073 wurde er bei dem Agricultural Research Service, Northern Research Laboratory, USA, hinterlegt
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP54017856A JPS5925599B2 (ja) | 1979-02-20 | 1979-02-20 | 新生理活性物質モナコリンkおよびその製造法 |
Publications (2)
Publication Number | Publication Date |
---|---|
DE3006216A1 DE3006216A1 (de) | 1980-09-04 |
DE3006216C2 true DE3006216C2 (de) | 1985-10-31 |
Family
ID=11955290
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE3051175A Expired DE3051175C2 (de) | 1979-02-20 | 1980-02-20 | |
DE3006216A Expired DE3006216C2 (de) | 1979-02-20 | 1980-02-20 | Monacolin K, Verfahren zu dessen Herstellung und diese Verbindung enthaltende Arzneimittel |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE3051175A Expired DE3051175C2 (de) | 1979-02-20 | 1980-02-20 |
Country Status (27)
Country | Link |
---|---|
JP (1) | JPS5925599B2 (de) |
KR (1) | KR830002801B1 (de) |
AT (1) | AT373915B (de) |
AU (1) | AU532626B2 (de) |
BE (1) | BE881825A (de) |
CA (1) | CA1129794A (de) |
CH (1) | CH645890A5 (de) |
DD (1) | DD154494A5 (de) |
DE (2) | DE3051175C2 (de) |
DK (2) | DK149095C (de) |
ES (1) | ES488796A0 (de) |
FI (1) | FI66427C (de) |
FR (1) | FR2449685B1 (de) |
GB (1) | GB2046737B (de) |
HU (1) | HU182069B (de) |
IE (1) | IE49743B1 (de) |
IT (1) | IT1175260B (de) |
MX (1) | MX6314E (de) |
NL (1) | NL191540C (de) |
NO (1) | NO153974C (de) |
NZ (1) | NZ192919A (de) |
PH (1) | PH15145A (de) |
PL (1) | PL124304B1 (de) |
SE (1) | SE453301B (de) |
SG (1) | SG6784G (de) |
SU (2) | SU1158048A3 (de) |
ZA (1) | ZA80962B (de) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS55150898A (en) * | 1979-05-11 | 1980-11-25 | Sankyo Co Ltd | Preparation of a new physiologically active substance mb-530b |
US4231938A (en) * | 1979-06-15 | 1980-11-04 | Merck & Co., Inc. | Hypocholesteremic fermentation products and process of preparation |
JPS5621594A (en) * | 1979-07-27 | 1981-02-28 | Sankyo Co Ltd | Mb-530b carboxylic acid metal salt and its preparation |
AU548996B2 (en) * | 1980-02-04 | 1986-01-09 | Merck & Co., Inc. | Tetrahydro-2h-pyran-2-one derivatives |
PT72394B (en) * | 1980-02-04 | 1982-09-06 | Merck & Co Inc | Process for preparing dihydro and tetrahydromevinoline hypocholesterolimics |
JPH0692381B2 (ja) * | 1980-03-31 | 1994-11-16 | 三共株式会社 | Mb−530a誘導体 |
JPS56142236A (en) | 1980-04-08 | 1981-11-06 | Sankyo Co Ltd | Ml-236a and mb-530a derivative |
MX7065E (es) * | 1980-06-06 | 1987-04-10 | Sankyo Co | Un procedimiento microbiologico para preparar derivados de ml-236b |
JPS5835144A (ja) * | 1981-08-27 | 1983-03-01 | Sankyo Co Ltd | Mb−530b誘導体およびその製造法 |
US4782084A (en) * | 1987-06-29 | 1988-11-01 | Merck & Co., Inc. | HMG-COA reductase inhibitors |
US4997848A (en) * | 1987-10-27 | 1991-03-05 | Sankyo Company, Limited | Octahydronaphthalene oxime derivatives for cholesterol synthesis inhibition |
CA2062023A1 (en) | 1992-02-10 | 1993-08-11 | Jagroop S. Dahiya | Novel fungal strains and use thereof in antibiotic production |
JPH07504568A (ja) * | 1992-03-04 | 1995-05-25 | 藤沢薬品工業株式会社 | HMG−CoAレダクターゼ阻害物質としてのテトラリン誘導体 |
ZA933359B (en) | 1992-05-15 | 1993-12-08 | Sankyo Co | Octahydronaphthalene oxime derivatives for cholesterol biosynthesis inhibition, their preparation and use |
HU210867B (en) * | 1992-11-04 | 1995-10-30 | Biogal Gyogyszergyar | Method for extraction and purification of mevinolin from culture medium |
US6812007B1 (en) * | 1992-11-04 | 2004-11-02 | Keri Vilmos | Process for the isolation and purification of mevinolin |
SI9300303A (en) * | 1993-06-08 | 1994-12-31 | Krka Tovarna Zdravil | Process for isolation of hypolipemic effective substance |
US5409820A (en) * | 1993-08-06 | 1995-04-25 | Apotex, Inc. | Process for the production of lovastatin using Coniothyrium fuckelii |
US7238348B2 (en) | 1996-09-30 | 2007-07-03 | Beijing Peking University Wbl Corporation Ltd. | Method of treatment of osteoporosis with compositions of red rice fermentation products |
US6046022A (en) | 1996-09-30 | 2000-04-04 | Peking University | Methods and compositions employing red rice fermentation products |
UA73074C2 (en) | 1998-03-20 | 2005-06-15 | Method of controlled fermentation for production of lovastatin as hydroxy-acid | |
CZ20022779A3 (cs) | 2000-02-24 | 2003-02-12 | Biogal Gyogyszergyar Rt. | Způsob purifikace fermentačního bujónu |
WO2001066538A1 (en) | 2000-03-03 | 2001-09-13 | Biogal Gyogyszergyar Rt. | A process for purifying lovastatin and simvastatin with reduced levels of dimeric impurities |
KR20010095780A (ko) * | 2000-04-12 | 2001-11-07 | 나가오카 마사시 | 배아 홍국 |
IN192861B (de) | 2000-06-30 | 2004-05-22 | Ranbaxy Lab Ltd | |
ATE356554T1 (de) * | 2001-02-09 | 2007-04-15 | Unilever Nv | Nahrungsmittel enthaltend sojaprotein und statin |
KR100379075B1 (en) | 2002-03-07 | 2003-04-08 | Jinis Biopharmaceuticals Co | Method for producing low cholesterol animal food product and food product therefrom |
KR20020093147A (ko) * | 2002-05-30 | 2002-12-13 | 지니스생명공학 주식회사 | 성인병 예방 및 치료 보조제 |
KR100710500B1 (ko) | 2005-05-18 | 2007-04-24 | 고려대학교 산학협력단 | 홍국균을 이용한 모나콜린 k 생산방법 |
SI2373609T1 (sl) | 2008-12-19 | 2013-12-31 | Krka, D.D., Novo Mesto | Uporaba amfifilnih spojin za kontrolirano kristalizacijo statinov in intermediatov statinov |
EP2327682A1 (de) | 2009-10-29 | 2011-06-01 | KRKA, D.D., Novo Mesto | Verwendung von amphiphilen Verbindungen zur gesteuerten Kristallisation von Statinen und Statin Zwischenprodukte. |
RO128803A0 (ro) | 2012-10-12 | 2013-09-30 | Ion Gigel Fulga | Compoziţie pentru tratamentul sau prevenirea dislipidemiilor |
CN110331151A (zh) * | 2019-04-11 | 2019-10-15 | 北京工商大学 | 紫色红曲菌mokH基因过表达菌株的构建方法 |
CN111297938A (zh) * | 2020-03-11 | 2020-06-19 | 北京康立生医药技术开发有限公司 | 一种辅助降血脂组合物中洛伐他汀的检测方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1453425A (en) | 1974-06-07 | 1976-10-20 | Sankyo Co | 2-oxo-tetrahydropyran derivatives and fermentative process for producing the same |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS55150898A (en) * | 1979-05-11 | 1980-11-25 | Sankyo Co Ltd | Preparation of a new physiologically active substance mb-530b |
IL60219A (en) * | 1979-06-15 | 1985-05-31 | Merck & Co Inc | Hypocholesteremic fermentation products of the hmg-coa reductase inhibitor type,their preparation and pharmaceutical compositions containing them |
-
1979
- 1979-02-20 JP JP54017856A patent/JPS5925599B2/ja not_active Expired
-
1980
- 1980-02-19 KR KR1019800000654A patent/KR830002801B1/ko active
- 1980-02-19 CA CA345,983A patent/CA1129794A/en not_active Expired
- 1980-02-19 IE IE321/80A patent/IE49743B1/en not_active IP Right Cessation
- 1980-02-19 AU AU55673/80A patent/AU532626B2/en not_active Expired
- 1980-02-20 DE DE3051175A patent/DE3051175C2/de not_active Expired
- 1980-02-20 NO NO800451A patent/NO153974C/no unknown
- 1980-02-20 MX MX808652U patent/MX6314E/es unknown
- 1980-02-20 DK DK73080A patent/DK149095C/da not_active IP Right Cessation
- 1980-02-20 SU SU802887300A patent/SU1158048A3/ru active
- 1980-02-20 PH PH23668A patent/PH15145A/en unknown
- 1980-02-20 ES ES488796A patent/ES488796A0/es active Granted
- 1980-02-20 FI FI800506A patent/FI66427C/fi not_active IP Right Cessation
- 1980-02-20 DD DD80219159A patent/DD154494A5/de unknown
- 1980-02-20 IT IT67262/80A patent/IT1175260B/it active
- 1980-02-20 HU HU80397A patent/HU182069B/hu unknown
- 1980-02-20 BE BE0/199476A patent/BE881825A/fr not_active IP Right Cessation
- 1980-02-20 NZ NZ192919A patent/NZ192919A/en unknown
- 1980-02-20 FR FR8003662A patent/FR2449685B1/fr not_active Expired
- 1980-02-20 PL PL1980222120A patent/PL124304B1/pl unknown
- 1980-02-20 SE SE8001339A patent/SE453301B/sv not_active IP Right Cessation
- 1980-02-20 AT AT0092980A patent/AT373915B/de not_active IP Right Cessation
- 1980-02-20 GB GB8005748A patent/GB2046737B/en not_active Expired
- 1980-02-20 DE DE3006216A patent/DE3006216C2/de not_active Expired
- 1980-02-20 CH CH136680A patent/CH645890A5/de not_active IP Right Cessation
- 1980-02-20 NL NL8001041A patent/NL191540C/xx not_active IP Right Cessation
- 1980-02-20 ZA ZA00800962A patent/ZA80962B/xx unknown
- 1980-09-12 SU SU802977031A patent/SU969702A1/ru active
-
1984
- 1984-01-24 SG SG67/84A patent/SG6784G/en unknown
-
1989
- 1989-01-18 DK DK021889A patent/DK21889D0/da not_active Application Discontinuation
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1453425A (en) | 1974-06-07 | 1976-10-20 | Sankyo Co | 2-oxo-tetrahydropyran derivatives and fermentative process for producing the same |
Non-Patent Citations (1)
Title |
---|
NICHTS-ERMITTELT |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3006216C2 (de) | Monacolin K, Verfahren zu dessen Herstellung und diese Verbindung enthaltende Arzneimittel | |
DE3006215C2 (de) | ||
DE2754326C2 (de) | Antibiotikum AM 2282, seine Herstellung und Arzneimittel | |
DE3028284C2 (de) | ||
DE3026214C2 (de) | ||
DE2849696A1 (de) | Verfahren zur herstellung des antibiotikums c-15003 p-3 | |
DE943717C (de) | Verfahren zur Herstellung und Gewinnung eines Antibiotikums | |
EP0019302A1 (de) | Neue tetracyclische Verbindungen, Verfahren zu deren Herstellung, deren Verwendung und pharmazeutische Präparate | |
DE3247175A1 (de) | Dihydro- und tetrahydromonacolin l, ihre metallsalze und alkylester sowie verfahren zu ihrer herstellung und sie enthaltende arzneimittel | |
CH640269A5 (de) | Verfahren zur herstellung des antibiotikums c-15003 p-4. | |
DE2316429A1 (de) | Verfahren zur herstellung eines neuen metaboliten | |
DE2510868C3 (de) | Nanaomycin A und Verfahren zur Herstellung der Antibiorica Nanaomycin A und Nanaomycin B | |
DE2254505A1 (de) | Verfahren zur herstellung von cephalosporin c | |
CH629531A5 (en) | Process for the preparation of the antibiotic A-30912 mixture and of factors A, B, C, D, E, F and G in this antibiotic mixture | |
DE1617346A1 (de) | 3'-Chlor-5,2'-dihydroxy-3,7,8-trimethoxy-flavon und Verfahren zu seiner Herstellung auf biologischem Wege | |
DE3312502A1 (de) | Physiologisch aktive substanzen ss 12538, ihre herstellung und neuer mikroorganismus zu ihrer herstellung | |
AT208999B (de) | Verfahren zur Herstellung von Pimaricin | |
EP0546474A1 (de) | Pseurotin F1/F2, neue Metabolite aus Aspergillus fumigatus, Verfahren zu ihrer Herstellung und ihre Verwendung als Apomorphin Antagonisten | |
EP0546475A1 (de) | Biologisch aktives Pseurotin A und D, neue Metabolite aus Aspergillus fumigatus, Verfahren zu ihrer Herstellung und ihre Verwendung als Apomorphin Antagonisten | |
DE19515650A1 (de) | Purpurogallin-Derivate | |
DE2044004C3 (de) | Verfahren zur Herstellung des Antibiotikumkomplexes Polyfungin | |
AT361619B (de) | Verfahren zur herstellung von neuen antibiotika | |
AT276628B (de) | Verfahren zur Herstellung der neuen entzündungswidrigen Substanz Zygosporin A | |
DE2659180C2 (de) | Antibiotisches Derivat der Substanz SF-1540 und Verfahren zu dessen Herstellung | |
CH359517A (de) | Verfahren zur Herstellung von Pimaricin |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8128 | New person/name/address of the agent |
Representative=s name: STREHL, P., DIPL.-ING. DIPL.-WIRTSCH.-ING. SCHUEBE |
|
8110 | Request for examination paragraph 44 | ||
D2 | Grant after examination | ||
8363 | Opposition against the patent | ||
8369 | Partition in: |
Ref document number: 3051099 Country of ref document: DE Format of ref document f/p: P |
|
Q171 | Divided out to: |
Ref country code: DE Ref document number: 3051099 |
|
8369 | Partition in: |
Ref document number: 3051175 Country of ref document: DE Format of ref document f/p: P |
|
Q171 | Divided out to: |
Ref country code: DE Ref document number: 3051175 |
|
AH | Division in |
Ref country code: DE Ref document number: 3051175 Format of ref document f/p: P |
|
8331 | Complete revocation |